Liver transplant study probes gut Compound's link to heart risk
NCT ID NCT06043531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a gut-related compound called TMAO affects heart health in 19 adults who had a liver transplant. Researchers measured TMAO levels and checked blood vessel function to understand why heart disease is more common after transplant. The goal was to gather knowledge, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can personalized antibiotics outsmart resistant bacteria in liver transplants?
- Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
- Could a daily pill shield transplant patients from a common virus?
- Which liver biopsy needle delivers the best tissue? a Head-to-Head comparison
- Transplant breakdown? new study checks organ fluid for hidden germs
- New study aims to catch transplant complications early with blood and urine tests